Concepedia

David Petullo

DP

Statistics

Publications

6

Citations

388

H-Index

6

Active since

1999

Affiliations

Eli Lilly (United States)(Current)

Human Genome Sciences (United States)

David Petullo is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug metabolism.

Publications per year

1999–2022

6

Publications

6

AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES

Matthew G. Soars, David Petullo, James A. Eckstein et al. · Drug Metabolism and Disposition · 2004 · 153 citations

Medicine, Biochemistry, Pharmacology +13

Model development and behavioral assessment of focal cerebral ischemia in rats

David Petullo, Kelly Masonic, Clint Lincoln et al. · Life Sciences · 1999 · 96 citations

Life Sciences, Neurobiology, Neuroscience +16

Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome

John‐Michael Sauer, Amanda Long, Barbara J. Ring et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 55 citations

Medicine, Pharmacokinetics, Pharmacology +17

A novel testosterone 6β-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro

Jessica L. Fayer, David Petullo, Barbara J. Ring et al. · Journal of Pharmacological and Toxicological Methods · 2001 · 33 citations

Medicine, Biochemistry, Pharmacology +13

Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective

Tao Liu, Rosemarie Neuner, Aliza Thompson et al. · Lupus · 2022 · 26 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

1–5 of 6